Total Payments
$1,634
2024 Payments
$115.22
Companies
16
Transactions
87
Medicare Patients
10,036
Medicare Billing
$520,267
Payment Breakdown by Category
Food & Beverage$1,610 (98.5%)
Education$24.90 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,610 | 85 | 98.5% |
| Education | $24.90 | 2 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $364.49 | 18 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $337.66 | 26 | $0 (2024) |
| Gilead Sciences Inc | $235.89 | 15 | $0 (2017) |
| BOSTON SCIENTIFIC CORPORATION | $158.91 | 4 | $0 (2021) |
| Edwards Lifesciences Corporation | $81.12 | 1 | $0 (2018) |
| Abbott Laboratories | $79.41 | 3 | $0 (2018) |
| PFIZER INC. | $71.46 | 6 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $58.24 | 1 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $50.26 | 1 | $0 (2018) |
| Amgen Inc. | $49.32 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.22 | 6 | Philips North America LLC ($24.55) |
| 2023 | $57.32 | 4 | PFIZER INC. ($43.95) |
| 2022 | $41.96 | 3 | PFIZER INC. ($16.18) |
| 2021 | $104.27 | 6 | E.R. Squibb & Sons, L.L.C. ($86.61) |
| 2020 | $111.63 | 7 | Medtronic Vascular, Inc. ($60.47) |
| 2019 | $153.05 | 7 | Medtronic Vascular, Inc. ($77.62) |
| 2018 | $643.09 | 33 | Medtronic Vascular, Inc. ($226.40) |
| 2017 | $407.92 | 21 | Gilead Sciences Inc ($235.89) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Cardiology | ||||||
| 06/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.18 | General |
| 05/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.76 | General |
| Category: Cardiovascular | ||||||
| 02/09/2024 | Philips North America LLC | (BR5) Peripheral IVUS (Device) | Food and Beverage | Cash or cash equivalent | $24.55 | General |
| Category: Medical Device | ||||||
| 08/24/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/18/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/04/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/17/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.89 | General |
| Category: Cardiovascular | ||||||
| 05/06/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/03/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.71 | General |
| Category: Cardiovascular | ||||||
| 10/06/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: Cardiovascular | ||||||
| 09/08/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: Cardiovascular | ||||||
| 08/25/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.08 | General |
| Category: Cardiovascular | ||||||
| 07/22/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.27 | General |
| Category: Cardiovascular | ||||||
| 05/11/2021 | BOSTON SCIENTIFIC CORPORATION | ELUVIA (Device) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/10/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.02 | General |
| Category: Cardiovascular | ||||||
| 11/11/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.83 | General |
| Category: Cardiovascular | ||||||
| 09/30/2020 | Boston Scientific Corporation | EKOSONIC (Device) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: THROMBECTOMY | ||||||
| 08/19/2020 | Medtronic Vascular, Inc. | Micra (Device) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Pacemakers | ||||||
| 06/10/2020 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 05/14/2020 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,818 | 2,669 | $294,621 | $92,820 |
| 2022 | 20 | 2,161 | 3,189 | $372,969 | $119,248 |
| 2021 | 23 | 2,788 | 3,965 | $464,872 | $152,430 |
| 2020 | 34 | 3,269 | 4,266 | $492,498 | $155,769 |
Total Patients
10,036
Total Services
14,089
Medicare Billing
$520,267
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 296 | 382 | $84,804 | $31,805 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 357 | 430 | $64,930 | $23,907 | 36.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 198 | 200 | $27,800 | $10,309 | 37.1% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 121 | 358 | $24,702 | $5,011 | 20.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 412 | 468 | $26,676 | $4,201 | 15.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 95 | 212 | $16,536 | $4,027 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $12,312 | $3,766 | 30.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 57 | 57 | $9,405 | $3,118 | 33.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 82 | 92 | $7,399 | $2,279 | 30.8% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 25 | 64 | $8,960 | $1,413 | 15.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 20 | 243 | $3,888 | $1,021 | 26.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 36 | 36 | $1,980 | $680.75 | 34.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 57 | 57 | $2,907 | $571.34 | 19.7% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 14 | 14 | $1,162 | $374.79 | 32.3% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 12 | 20 | $1,160 | $337.11 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 290 | 401 | $89,022 | $33,951 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 454 | 593 | $89,543 | $33,104 | 37.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 217 | 220 | $30,580 | $10,755 | 35.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 101 | 266 | $20,748 | $5,048 | 24.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 463 | 525 | $29,925 | $4,718 | 15.8% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 129 | 345 | $23,805 | $4,706 | 19.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $15,390 | $4,591 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 30 | $8,940 | $3,682 | 41.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 65 | 65 | $10,725 | $3,561 | 33.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 100 | 116 | $9,319 | $2,952 | 31.7% |
About Dr. Gary Dykstra, D.O
Dr. Gary Dykstra, D.O is a Cardiovascular Disease healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033172192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Dykstra, D.O has received a total of $1,634 in payments from pharmaceutical and medical device companies, with $115.22 received in 2024. These payments were reported across 87 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,610).
As a Medicare-enrolled provider, Dykstra has provided services to 10,036 Medicare beneficiaries, totaling 14,089 services with total Medicare billing of $520,267. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Bartlesville, OK
- Active Since 04/10/2006
- Last Updated 11/04/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1033172192
Products in Payments
- ELIQUIS (Drug) $391.27
- TYRX (Device) $266.49
- Ranexa (Drug) $188.72
- WATCHMAN (Device) $123.94
- ENTRESTO (Drug) $58.24
- Micra (Device) $56.21
- Circulatory Support (Device) $55.01
- Adempas (Drug) $50.26
- EKOSONIC (Device) $47.38
- FARXIGA (Drug) $31.61
- XARELTO (Drug) $31.28
- Reveal LINQ (Device) $30.23
- Corlanor (Drug) $27.22
- (BR5) Peripheral IVUS (Device) $24.55
- HeartMate (Device) $24.40
- Repatha (Biological) $22.10
- ELUVIA (Device) $17.66
- CAMZYOS (Drug) $11.89
- Endurant (Device) $11.56
- PRALUENT (Biological) $11.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Bartlesville
Dr. Anderson Mehrle, Md, MD
Cardiovascular Disease — Payments: $98,330
Cardiovascular Disease $98,330
Dr. Kathryn Farguson, D.o, D.O
Cardiovascular Disease — Payments: $7,111
Cardiovascular Disease $7,111
William Tinker, M.d, M.D
Cardiovascular Disease — Payments: $3,645
Cardiovascular Disease $3,645